Novo Holdings Completes $16.5-Bn Acquisition of Catalent 
By

By
Novo Holdings, the parent company of Novo Nordisk, has completed its acquisition of Catalent for $16.5 billion. The deal was announced in February 2024.  Novo’s interest to increase manufacturing capacity,…

Lilly Investing $3-Bn in Injectable Mfg Expansion 
By

By
Eli Lilly and Company has announced a $3-billion expansion of its sterile manufacturing facility in Pleasant Prairie, Wisconsin. Lilly had acquired the facility earlier this year (2024) from Nexus Pharmaceuticals,…

AbbVie Completes $1.4-Bn Acquisition of Aliada Therapeutics 
By

By
AbbVie has completed its $1.4-billion acquisition of Aliada Therapeutics, a bio/pharmaceutical company focused on central nervous system (CNS) diseases, for $1.4 billion. The companies had announced the acquisition in October…

Supplier News: Euroapi & SK pharmteco 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Euroapi & SK pharmteco.   Chemicals/Chemical API Manufacturing* Euroapi Names New Chair & CEO General * SK pharmteco Consolidates Brands into One Company Chemicals/Chemical API…

Partnering News: Gilead, Takeda & More 
By

By
A roundup of bio/pharmaceutical partnering news from Gilead/Tubulis and Takeda/Keros.  * Gilead, Tubulis In $465-M ADC Cancer Drug Pact * Takeda, Keros Therapeutics in $200-M Cancer Drug Licensing Pact  Gilead, Tubulis…

Sanofi To Invest $1.05 Bn in New Insulin Mfg Base in China 
By

By
Sanofi has signed a memorandum of cooperation with the Beijing Municipal Bureau of Economy and Information Technology and the Beijing Economic and Technological Development Zone to establish a new EUR…

Amgen Investing $1 Bn in New Drug-Substance Mfg Facility 
By

By
Amgen has announced a $1-billion expansion to establish a second drug substance manufacturing facility in Holly Springs, North Carolina. This brings the company’s total planned investment in Holly Springs to…

Roche To Acquire Poseida Therapeutics in $1.5-Bn Deal 
By

By
Roche has agreed to acquire Poseida Therapeutics, a San Diego, California-based clinical-stage cell- and gene-therapy company developing treatments for cancer, autoimmune, and rare diseases, in a $1.5-billion deal ($1.0 billion…

Supplier News: Resilience, Cambrex, Agilent & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Resilience, Sartorius, Agilent, Cambrex, Evotec, Hovione and Samabriva.   Biologics Manufacturing * Resilience Names New CEO * Sartorius Opens New Center for Bioprocess Innovation * Samabriva…

Global Briefs: Novo Nordisk, Coherus & More 
By

By
A roundup of news from Novo Nordisk, Novavax, Coherus BioSciences and Intas Pharmaceuticals. Highlights below.   General * Novo Nordisk Investing $411 M in New Quality Control Facility Mfg News * Novo Nordisk To…